LENZ Therapeutics, Inc. (LENZ)
3.79
+0.20
(+5.57%)
USD |
NASDAQ |
Oct 06, 16:00
3.72
-0.07
(-1.85%)
Pre-Market: 08:20
LENZ Therapeutics EPS Diluted (Quarterly) : -1.017 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.017 |
| March 31, 2026 | -1.323 |
| December 31, 2025 | -1.155 |
| September 30, 2025 | -0.5851 |
| June 30, 2025 | -0.5311 |
| March 31, 2025 | -0.5311 |
| December 31, 2024 | -0.4602 |
| September 30, 2024 | -0.3759 |
| June 30, 2024 | -0.4004 |
| March 31, 2024 | -3.529 |
| December 31, 2023 | -84.29 |
| September 30, 2023 | -9.624 |
| June 30, 2023 | -7.528 |
| Date | Value |
|---|---|
| March 31, 2023 | -6.495 |
| December 31, 2022 | -3.090 |
| September 30, 2022 | -3.130 |
| June 30, 2022 | -3.420 |
| March 31, 2022 | -3.389 |
| December 31, 2021 | -2.292 |
| September 30, 2021 | -1.759 |
| June 30, 2021 | -2.192 |
| March 31, 2021 | -2.376 |
| December 31, 2020 | -7.658 |
| September 30, 2020 | -0.4079 |
| June 30, 2020 | -0.1581 |
| March 31, 2020 | -0.017 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Impact BioMedical, Inc. | -0.0818 |
| Enveric Biosciences, Inc. | -0.7594 |
| Liquidia Corp. | 0.7369 |
| Aquestive Therapeutics, Inc. | -0.1829 |
| ANI Pharmaceuticals, Inc. | 1.052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -31.92M |
| Revenue (Quarterly) | 5.486M |
| Total Expenses (Quarterly) | 37.40M |
| Enterprise Value | -100.36M |
| Gross Profit Margin (Quarterly) | 94.90% |
| Profit Margin (Quarterly) | -581.8% |
| Earnings Yield | -107.7% |
| Normalized Earnings Yield | -107.68 |